Bausch + Lomb Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BLCO New York 2834 www.bausch.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bausch + Lomb Corporation

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program - Apr 16th, 2026 5:00 am
Macugen (Bausch + Lomb: pegaptanib sodium) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F - Apr 13th, 2026 5:50 am
3 Cash-Burning Stocks We Keep Off Our Radar - Apr 10th, 2026 11:58 am
Bausch Lomb Expands Surgical Toolkit With New Retina And Lens Systems - Apr 9th, 2026 9:10 pm
Sector Update: Health Care Stocks Advance Late Afternoon - Apr 8th, 2026 1:44 pm
Sector Update: Health Care Stocks Advance in Afternoon Trading - Apr 8th, 2026 11:59 am
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update - Apr 8th, 2026 5:00 am
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off - Apr 8th, 2026 3:01 am
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe - Apr 7th, 2026 5:00 am
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting - Apr 6th, 2026 5:00 am
Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks - Apr 2nd, 2026 2:16 am
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29 - Mar 30th, 2026 5:15 am
A Look At Bausch + Lomb (BLCO) Valuation After Recent Share Price Pullback - Mar 27th, 2026 9:06 pm
Bausch + Lomb Spotlights BL 1107 Eye Drop and ELIOS Implant-Free Laser as Glaucoma Catalysts - Mar 27th, 2026 1:06 am
3 Reasons BLCO is Risky and 1 Stock to Buy Instead - Mar 26th, 2026 8:07 am
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story - Mar 24th, 2026 5:44 pm
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday - Mar 23rd, 2026 7:12 am
Bausch + Lomb Higher in New York Trading, Reports Positive Elios Trial Results - Mar 23rd, 2026 5:52 am
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma - Mar 23rd, 2026 5:00 am
Is It Time To Reconsider Bausch + Lomb (BLCO) After Recent Share Price Weakness - Mar 15th, 2026 10:10 am